Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (41 ops.)
Latest filing published 12 Aug 2026 for Organon & Co..
Filing timeline
BuySaleFerreira Juan Camilo Arjona
Insider track record
Disclosed buys
0
Disclosed sells
41
Signal history
Ferreira Juan Camilo Arjona: trading record in brief
Ferreira Juan Camilo Arjona filed 83 reports between August 17, 2017 and August 12, 2026. At Myovant Sciences Ltd. (67 filings) the listed title is Chief Medical Officer; at Organon & Co. (16 filings), Head of R&D & CMO.
Forty-one sales and no purchase. The total reaches EUR 3.4 million with a median of EUR 44,842: many small trades, few large ones. The three largest are at Myovant: EUR 428,121 on August 30, 2021, EUR 310,127 on June 24, 2020 and EUR 252,384 on May 26, 2021. The rest of the record is 27 option exercises, 13 grants and 2 filings of another nature.
Two years hold most of the activity: 28 filings in 2020 and 22 in 2021, against 4 in both 2023 and 2024. Over the last twelve months, 8 filings and no sale.
Filings appear a median of 2 days after the trade. At Myovant, 30 of Arjona's trades fall within 30 days of a trade by Matthew Lang, 17 of Frank Karbe and 9 of David C. Marek, all in the same direction.
Companies and markets linked to Ferreira Juan Camilo Arjona
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations83 total
11,519 shares0Common StockSEC:0001628280-26-056061:0
4,134 shares@ US$13.620.0015% mcap36.2% of flowCommon StockSEC:0001628280-26-056061:1
13,431 shares0Common StockSEC:0001628280-26-023188:0
4,820 shares@ US$5.7017.6% of flowCommon StockSEC:0001628280-26-023188:1
8,865 shares0Common StockSEC:0001628280-26-022387:0
3,181 shares@ US$5.840.0005% mcap12.0% of flowCommon StockSEC:0001628280-26-022387:1
6,446 shares0Common StockSEC:0001628280-25-051052:0
2,307 shares@ US$6.719.9% of flowCommon StockSEC:0001628280-25-051052:1
4,122 shares@ US$9.2224.3% of flowCommon StockSEC:0001821825-25-000068:1
11,519 shares0Common StockSEC:0001821825-25-000068:0
3,172 shares@ US$14.5114.9% of flowCommon StockSEC:0001821825-25-000012:1
8,865 shares0Common StockSEC:0001821825-25-000012:0
2,300 shares@ US$15.8011.9% of flowCommon StockSEC:0001821825-24-000110:1
6,446 shares0Common StockSEC:0001821825-24-000110:0
3,991 shares@ US$20.1525.9% of flowCommon StockSEC:0001821825-24-000085:1
11,519 shares0Common StockSEC:0001821825-24-000085:0
160,082 sharesCommon SharesSEC:0001209191-23-017715:1
86,602 sharesCommon SharesSEC:0001209191-23-017715:0
1,109 shares@ US$26.894.0% of flowCommon SharesSEC:0001209191-23-004277:0
2,251 shares@ US$26.908.3% of flowCommon SharesSEC:0001209191-23-001957:0
1,604 shares@ US$25.205.9% of flowCommon SharesSEC:0001209191-22-054194:0
2,738 shares@ US$24.409.6% of flowCommon SharesSEC:0001209191-22-052986:0
1,606 shares@ US$12.872.9% of flowCommon SharesSEC:0001209191-22-042686:0
2,755 shares@ US$13.405.2% of flowCommon SharesSEC:0001209191-22-041618:0
1,382 shares@ US$10.071.9% of flowCommon SharesSEC:0001209191-22-033156:0
25 of 83 declarations
